FDA Grants Profounda Orphan Drug Designation Approval for Treatment of Invasive Candidiasis with Miltefosine

Invasive candidiasis is an infection caused by a yeast (a type of fungus) called Candida. and is a serious infection that can affect the blood, heart, brain, eyes, bones, or other parts of the body In the United States, candidemia is one of the most com... Biopharmaceuticals, FDA Profounda, Impavido, miltefosine, leishmaniasis, candidiasis
Source: HSMN NewsFeed - Category: Pharmaceuticals Source Type: news